Skip to content

Clinical trials

Completed Phase 1/2 Brain Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 1/2 Status: Completed Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20016
20027
20033
20044
20053
20064
20072
20094
20106
20115
20125
20133
20143
20152
20162
20173
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)12
New Approaches to Brain Tumor Therapy Consortium7
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins6
M.D. Anderson Cancer Center5
Duke University3
Novartis Pharmaceuticals3
Jonsson Comprehensive Cancer Center2
Memorial Sloan Kettering Cancer Center2
Northwell Health2
Abramson Cancer Center at Penn Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms78
Glioblastoma58
Gliosarcoma39
Central Nervous System Neoplasms30
Glioma30
Astrocytoma29
Oligodendroglioma23
Ependymoma5
Neoplasm Metastasis5
Carcinoma, Non-Small-Cell Lung4

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.